Quest credits FDA with speeding COVID-19 testing, turnaround times

Maia Anderson –
Thursday, July 30th, 2020
Print|Email.

The approach speeds the extraction of viral RNA from COVID-19 test samples and can be used in pooled testing to more increase capability..

Mission said it expects to be able to carry out 150,000 tests each day by next week and 185,000 each day by Labor Day..

More articles on supply chain: FDA puts hand sanitizers on import alert, adds more to do-not-use listFreight, shipping business state theyre not ready to disperse COVID-19 vaccineSee-through masks in high need as COVID-19 cases rise.

Quest Diagnostics said July 29 that the FDA has actually granted emergency situation usage permission for a brand-new lab method that accelerates the COVID-19 testing process and will enable it to broaden its daily testing capability and improve turnaround times..

Quest now can carry out 135,000 tests daily, and the brand-new technique is anticipated to add another 35,000 tests per day in the next a number of weeks.

The brand-new technique will help Quest to speed typical turnaround times to one day for priority clients and 2 to 3 days for all other patients, the company said..
Check out the full press release here.

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this material? View our policies by clicking here.